###begin article-title 0
###xml 87 92 <span type="species:ncbi:9606">Human</span>
A Functional gammadeltaTCR/CD3 Complex Distinct from gammadeltaT Cells Is Expressed by Human Eosinophils
###end article-title 0
###begin p 1
Conceived and designed the experiments: FL VD GW FS DDD MC. Performed the experiments: FL VD GW SL EH LH VM FS. Analyzed the data: FL VD GW SL JJF MLG DDD MC. Contributed reagents/materials/analysis tools: JJF. Wrote the paper: DDD MC.
###end p 1
###begin p 2
paragraph sign These authors also contribued equally to this work.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
Eosinophils are effector cells during parasitic infections and allergic responses. However, their contribution to innate immunity has been only recently unravelled.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 597 604 550 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
Here we show that human eosinophils express CD3 and gammadelta T Cell Receptor (TCR) but not alphabeta TCR. Surface expression of gammadeltaTCR/CD3 is heterogeneous between eosinophil donors and inducible by mycobacterial ligands. Surface immunoprecipitation revealed expression of the full gammadeltaTCR/CD3 complex. Real-time PCR amplification for CD3, gamma and delta TCR constant regions transcripts showed a significantly lower expression in eosinophils than in gammadeltaT cells. Limited TCR rearrangements occur in eosinophils as shown by spectratyping analysis of CDR3 length profiles and in situ hybridization. Release by eosinophils of Reactive Oxygen Species, granule proteins, Eosinophil Peroxidase and Eosinophil-Derived Neurotoxin and cytokines (IFN-gamma and TNF-alpha) was observed following activation by gammadeltaTCR-specific agonists or by mycobacteria. These effects were inhibited by anti-gammadeltaTCR blocking antibodies and antagonists. Moreover, gammadeltaTCR/CD3 was involved in eosinophil cytotoxicity against tumor cells.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 34 39 <span type="species:ncbi:9606">human</span>
Our results provide evidence that human eosinophils express a functional gammadeltaTCR/CD3 with similar, but not identical, characteristics to gammadeltaTCR from gammadeltaT cells. We propose that this receptor contributes to eosinophil innate responses against mycobacteria and tumors and may represent an additional link between lymphoid and myeloid lineages.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Giembycz1">[1]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Rothenberg1">[2]</xref>
###xml 334 337 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Rothenberg1">[2]</xref>
###xml 464 467 464 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Jacobsen1">[3]</xref>
###xml 469 472 469 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Walsh1">[4]</xref>
###xml 710 713 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Young1">[5]</xref>
###xml 715 718 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Gounni1">[6]</xref>
###xml 768 771 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Stenfeldt1">[7]</xref>
###xml 786 789 786 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Jacobsen2">[8]</xref>
###xml 919 922 919 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Rothenberg1">[2]</xref>
###xml 1002 1005 1002 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Kayaba1">[9]</xref>
Eosinophils are polymorphonuclear granulocytes mainly found in increased numbers during helminth parasitic infections and allergic reactions [1], [2]. They are classically considered as mediator-releasing cells during effector phase of adaptive immunity, under the influence of T cell dependent cytokines or chemokines and antibodies [2], whereas eosinophil-derived chemokines have been recently shown to locally attract Th2 lymphocytes at lung inflammatory sites [3], [4]. Nevertheless, their precise function as beneficial or deleterious to the host still remains ambiguous, since highly toxic proteins present in eosinophil granules exert potent cytotoxic effects against non self targets such as parasites [5], [6] but also against stressed or necrotic host cells [7] and in asthma [8]. Eosinophils are foremost present in mucosal tissues in contact with the environment such as in gastro-intestinal tract and skin [2] and are characterized by their wide morphological and functional heterogeneity [9].
###end p 10
###begin p 11
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly1">[10]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly2">[11]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Melo1">[12]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly1">[10]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lucey1">[13]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Seton1">[14]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Shi1">[15]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Plumas1">[16]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Simon1">[17]</xref>
###xml 436 440 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lucey2">[18]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly1">[10]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Seton1">[14]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Munitz1">[19]</xref>
In addition to these effector functions, eosinophils produce several Th1, Th2 and regulatory cytokines, such as IL-10 [10], [11], which, in contrast to T cells, are stored within granules and promptly released upon activation [12]. Eosinophils also express MHCII and CD86 [10], [13], [14] and act as antigen-presenting cells [15]. Furthermore, eosinophils share with T cells expression of various receptors such as CD25 [16], [17], CD4 [18], CD28 [10], [14] and several members of the CD2 family, including 2B4 [19]. This wide array of molecules endows eosinophils with the ability to induce and regulate adaptive immunity.
###end p 11
###begin p 12
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Rowley1">[20]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Svensson1">[21]</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Miike1">[22]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Bolton1">[23]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Driss1">[24]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Nagase1">[25]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Phipps1">[26]</xref>
###xml 614 618 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Driss1">[24]</xref>
###xml 751 755 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Yousefi1">[27]</xref>
###xml 875 879 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Tepper1">[28]</xref>
###xml 881 885 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Tepper2">[29]</xref>
###xml 523 528 <span type="species:ncbi:9606">human</span>
However, the early appearance of eosinophils in agnathans, predating the appearance of the classical adaptive immune system [20] and the expression by eosinophils of several receptors involved in innate immunity, such as formyl peptide receptor [21], protease-activated receptors [22], [23] and TLR [24] further point toward a role for eosinophils in innate immunity. Eosinophils contribute to TLR-mediated immunity against viruses and mycobacteria [25], [26]. Indeed, we recently showed that TLR-2-dependent activation of human eosinophils induced alpha-defensin and ECP release and decreased mycobacteria growth [24]. Furthermore, expulsion of mitochondrial DNA by eosinophils has been shown to contribute to innate immune defences against bacteria [27]. Finally, eosinophil-tumor cell interactions and IL-4-dependent tumoricidal activity of eosinophils have been reported [28], [29]. Thus eosinophils appear functionally located at the interface between innate and adaptive immunity.
###end p 12
###begin p 13
###xml 271 275 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Brandes1">[30]</xref>
###xml 386 390 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Hayday1">[31]</xref>
###xml 392 396 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Carding1">[32]</xref>
Strikingly, gammadeltaT cells are ancestral to other lymphoid populations such as alphabetaT cells and B cells, they participate to both innate and adaptive immune responses, have a preferential mucosal localisation and might act as professional antigen-presenting cells [30] recognizing non-peptide antigens found on several pathogens, including mycobacteria, necrotic and tumor cells [31], [32].
###end p 13
###begin p 14
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
These surprising similarities between gammadeltaT cells and eosinophils prompted us to investigate, whether, in addition to other T cell-associated receptors, human eosinophils expressed a gammadeltaT cell Receptor (TCR). We here report that human blood eosinophils express low levels of surface gammadeltaTCR/CD3, inducible by mycobacterial ligands. We show that eosinophils release granule proteins and cytokines upon activation by gammadeltaTCR agonists, including mycobacteria. Furthermore, we provide evidence that gammadeltaTCR contributes to eosinophil cytotoxic potential towards tumors.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human eosinophils express CD3 and gammadeltaTCR but not alphabetaTCR
###end title 16
###begin p 17
###xml 197 207 197 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s001">Figure S1A</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Metso1">[33]</xref>
###xml 405 415 405 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s001">Figure S1B</xref>
###xml 474 484 474 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s001">Figure S1B</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
In order to investigate expression by human blood eosinophils of T cell associated receptors, we purified eosinophils by negative selection using magnetic beads. These highly purified eosinophils (Figure S1A) expressed specific granule proteins such as eosinophil peroxidase (EPO) and major basic protein (MBP) but not myeloperoxidase (MPO) associated to neutrophil and monocyte/macrophage lineages [33] (Figure S1B). Lymphocytes expressed neither of these myeloid markers (Figure S1B).
###end p 17
###begin p 18
###xml 105 114 105 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1A</xref>
###xml 277 286 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1A</xref>
###xml 379 388 349 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1B</xref>
###xml 419 423 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Puellmann1">[34]</xref>
###xml 497 506 460 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1C</xref>
###xml 588 597 543 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1C</xref>
Following permeabilization, binding of anti-CD3 but not anti-CD8 antibodies was detected in eosinophils (Figure 1A). In T cells, CD3 associates with either alphabetaTCR or gammadeltaTCR. We did not detect alphabetaTCR on eosinophils but gammadeltaTCR expression was evidenced (Figure 1A). While lymphocytes from PBMC fraction expressed these markers at the expected frequencies (Figure 1B) and unlike a previous report [34], we were unable to detect CD3 or alphabetaTCR expression in neutrophils (Figure 1C). Likewise neither CD8 nor gammadeltaTCR expression was detected in neutrophils (Figure 1C).
###end p 18
###begin title 19
###xml 43 48 <span type="species:ncbi:9606">human</span>
Expression of gammadeltaTCR/CD3 complex by human eosinophils.
###end title 19
###begin p 20
###xml 103 112 88 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s001">Figure S1</xref>
(A-C) CD3, CD8, alphabetaTCR and gammadeltaTCR expression on permeabilized cells gated as described in Figure S1 (A) purified peripheral blood eosinophils (B) lymphocytes and (C) neutrophils. Staining with control isotype matched antibodies is represented in white histograms.
###end p 20
###begin p 21
###xml 182 191 174 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2A</xref>
###xml 201 210 193 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2B</xref>
###xml 415 426 392 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2A&#8211;B</xref>
###xml 492 493 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 577 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2C</xref>
###xml 700 701 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 708 709 657 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 829 840 758 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2A&#8211;C</xref>
###xml 583 588 <span type="species:ncbi:9606">human</span>
Surface expression of CD3 and gammadeltaTCR was detected on a fraction of eosinophils following double staining with antibodies against two specific eosinophil granule proteins EPO (Figure 2A) or MBP (Figure 2B). Similarly to intracellular staining, neither CD8 nor alphabetaTCR were detected at eosinophil surface. By contrast, another gammadeltaT cell marker, NKG2D, was expressed in a lower proportion of cells (Figure 2A-B). As CD3 is required for receptor complex surface expression, CD3+gammadeltaTCR+ eosinophils were thus identified following triple staining (Figure 2C). In human blood, gammadeltaT cells express either Vgamma9/Vdelta2 or Vdelta1 variable regions. We also evidenced that EPO+ or MBP+ eosinophils expressed Vgamma9, Vdelta1 and Vdelta2 and unexpectedly co-expressed Vdelta1 and Vdelta2 at their surface (Figure 2A-C).
###end p 21
###begin title 22
###xml 51 56 <span type="species:ncbi:9606">human</span>
Surface expression of gammadeltaTCR/CD3 complex by human eosinophils.
###end title 22
###begin p 23
###xml 106 107 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 120 121 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 218 227 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s001">Figure S1</xref>
###xml 375 376 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 389 390 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 393 394 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 406 407 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 414 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 417 418 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A-C) CD3, gammadeltaTCR, Vgamma9, Vdelta2, Vdelta1, alphabetaTCR, CD8 and NKG2D surface expression on EPO+ (A) and MBP2+ (B) purified peripheral blood eosinophils analysed after 18 h culture and gated as described in Figure S1. Results in (A) and (B) represent to 2 distinct representative donors. Staining with control isotype antibodies is represented. (C) Presence of CD3+gammadeltaTCR+EPO+ and Vdelta1+delta2+EPO+ eosinophils identified by triple staining. Staining with control isotype matched antibodies as well as corresponding double stainings is represented.
###end p 23
###begin p 24
###xml 482 493 466 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g003">Figure 3A&#8211;B</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Expression of gammadeltaTCR/CD3 complex was investigated in healthy donors and patients with either reactive eosinophilia (allergies, various skin diseases) or hypereosinophilic syndrome (HES). A wide heterogeneity of surface expression of gammadeltaTCR/CD3 and NKG2D was not only found among the 23 donors but also within each group, including healthy donors, however no correlation was observed between receptor expression levels and either eosinophilia, or a specific pathology (Figure 3A-B).
###end p 24
###begin title 25
###xml 68 73 <span type="species:ncbi:9606">human</span>
Heterogeneity of surface expression of gammadeltaTCR/CD3 complex by human eosinophils.
###end title 25
###begin p 26
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 211 218 <span type="species:ncbi:9606">patient</span>
(A) Cell surface marker expression on EPO+ gated peripheral blood eosinophils from 23 individual eosinophil donors. Group average expression for the indicated markers is represented (-). (B) Individual data and patient status.
###end p 26
###begin p 27
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 159 169 131 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s002">Figure S2A</xref>
###xml 359 369 308 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s002">Figure S2B</xref>
###xml 438 448 379 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s002">Figure S2C</xref>
###xml 561 571 487 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s002">Figure S2D</xref>
Following in vitro activation of gammadeltaT cells, CD3, CD8, gammadeltaTCR as well as Vgamma9, Vdelta2 and Vdelta1 were detected at the expected frequencies (Figure S2A). Likewise, freshly isolated PBMC from the same eosinophil donors, in which gammadeltaT cells represent a very minor population, expressed CD3, alphabetaTCR or low levels of gammadeltaTCR (Figure S2B). By contrast, monocytes did neither express CD3 nor gammadeltaTCR (Figure S2C). Finally, neutrophils neither expressed CD3, gammadeltaTCR nor the full alphabetaTCR complex at their surface (Figure S2D). Thus, following overnight culture, a fraction of eosinophils, unambiguously identified by the presence of specific eosinophil markers, express the gammadeltaTCR/CD3 complex at their surface.
###end p 27
###begin p 28
###xml 121 125 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Boullier1">[35]</xref>
###xml 264 267 250 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Kayaba1">[9]</xref>
###xml 506 516 468 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s003">Figure S3A</xref>
###xml 591 617 553 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 617 621 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Constant1">[36]</xref>
###xml 698 708 652 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s003">Figure S3B</xref>
###xml 804 814 751 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s003">Figure S3B</xref>
###xml 390 395 <span type="species:ncbi:9606">human</span>
###xml 591 617 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Besides receptor reexpression at the membrane following a resting period, as demonstrated for NKG2A on gammadeltaT cells [35], ligand-dependent induction or upregulation of receptor surface expression has been widely reported, including in the case of FcepsilonRI [9]. Thus, we investigated whether a specific gammadeltaTCR ligand was able to induce gammadeltaTCR/CD3 surface expression on human eosinophils. While CD3 and gammadeltaTCR were barely detected at the surface of freshly purified eosinophils (Figure S3A), upon incubation for 2 h with TUBag1, a natural non peptidic ligand from Mycobacterium tuberculosis[36], about 50% of eosinophils expressed CD3 and gammadeltaTCR at their surface (Figure S3B). By contrast, neither CD8 nor alphabetaTCR expression was induced upon incubation with TUBag (Figure S3B).
###end p 28
###begin p 29
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 319 328 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s004">Figure S4</xref>
Finally, besides mature eosinophils present in peripheral blood, eosinophils can be differentiated in vitro from CD34+ cord blood progenitors. In such EPO+ eosinophils, in the absence of possible contamination by gammadeltaT cells, gammadeltaTCR/CD3 complex was detected at cell surface, after 3 weeks differentiation (Figure S4). As for blood eosinophils, neither CD8 nor alphabetaTCR (not shown) could be detected.
###end p 29
###begin title 30
Eosinophils express all the subunits from gammadeltaTCR/CD3 complex
###end title 30
###begin p 31
###xml 619 625 588 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g004">Fig 4A</xref>
###xml 1102 1111 1030 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g004">Figure 4B</xref>
###xml 1468 1476 1372 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g002">Figure 2</xref>
###xml 1481 1490 1385 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s002">Figure S2</xref>
To evidence the cellular distribution of gammadeltaTCR/CD3 complex and to further exclude that results obtained by flow cytometry could be due to contaminating gammadeltaT cells, blood eosinophils were analysed at low magnification by immunofluorescence and at high magnification by confocal microscopy. In full agreement with flow cytometry data, in a preparation without contaminating cells, only a fraction of blood eosinophils, identified by their typical binucleated morphology, expressed the four chains of CD3 and gammadeltaTCR. No signal was detected with anti-alphaTCR, anti-betaTCR antibodies or control IgG (Fig 4A). We next characterized the structure of the gammadeltaTCR/CD3 complex expressed at the surface of eosinophils, using surface biotinylation, followed by lysis with a mild detergent, co-immunoprecipitation with an anti-gammadeltaTCR antibody, SDS-PAGE in reducing conditions and detection of biotinylated proteins. Bands corresponding to TCR, CD3delta, epsilon, gamma and zeta subunits were detected at the expected molecular weights both on gammadeltaT cells and eosinophils (Figure 4B). This result indicates that all the necessary chains are present to allow for surface expression of a complete gammadeltaTCR/CD3. However, the amount of material used for eosinophils was 10 times higher than for gammadeltaT cells, results consistent with flow cytometry data showing much lower surface expression in eosinophils than in gammadeltaT cells (Figure 2 and Figure S2).
###end p 31
###begin title 32
###xml 93 98 <span type="species:ncbi:9606">human</span>
Immunolocalization and Subunit composition of surface-expressed gammadeltaTCR/CD3 complex on human eosinophils.
###end title 32
###begin p 33
###xml 746 748 715 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 225 229 <span type="species:ncbi:9925">goat</span>
(A) Immunofluorescence and confocal microscopy (insets) analysis of gammadeltaTCR/CD3 chains expression on cytospin eosinophil preparations after 18 h culture. Staining with anti-alphaTCR, anti-betaTCR antibodies and control goat IgG is represented. Arrowheads indicate some positive cells. (B) Surface of eosinophils and gammadeltaT cells was biotin-labelled. Cells were lysed and complexes were immunoprecipitated, using anti-gammadeltaTCR or isotype control antibodies. Immunoprecipitated proteins were resolved on a reducing 14% SDS-PAGE and transferred to PVDF membrane. Biotinylated proteins were revealed using ABC-HRP and chemiluminescence. Positions of the TCR and CD3 subunits are marked. Material corresponding to the total and to 1/10th of the material was loaded for eosinophils and gammadeltaT cells respectively. Dashed lines indicate that non adjacent lanes of the same gel have been joined on the Figure.
###end p 33
###begin title 34
gammadeltaTCR/CD3 is less abundant and more restricted in eosinophils than in gammadeltaT cells
###end title 34
###begin p 35
###xml 563 572 514 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g005">Figure 5A</xref>
###xml 846 855 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g005">Figure 5B</xref>
###xml 1064 1073 928 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g005">Figure 5C</xref>
###xml 1326 1333 1182 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1810 1817 1642 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g005">Fig. 5D</xref>
###xml 268 272 <span type="species:ncbi:307630">Colo</span>
###xml 830 834 <span type="species:ncbi:307630">Colo</span>
Transcripts specific for the four chains (epsilon, zeta, gamma and delta) of CD3 complex, gammaTCR and deltaTCR constant regions and CD8 were amplified and quantified by real-time PCR in eosinophils purified to homogeneity (100%) and gammadeltaT lymphocyte subsets or Colo-205 colon carcinoma cells as positive and negative controls respectively. Expression of the various chains was 300 to 4,000 fold lower in eosinophil population than in gammadeltaT lymphocyte population, while CD8 expression was absent in eosinophils but present in gammadeltaT lymphocytes (Figure 5A). Amplification of Vdelta1-Jdelta3, Vdelta2-Cdelta and VgammaI-JgammaP rearranged transcripts but not Vdelta1-Jdelta4 was also detected in eosinophils. These rearrangements were all found in gammadeltaT lymphocytes but neither in alphabetaT lymphocytes nor Colo-205 cells (Figure 5B). Spectratyping analysis of CDR3 length profiles for Vgamma9-Jgamma1/2, Vgamma9-JgammaP and Vdelta2-Cdelta evidenced a limited Vdelta2-Cdelta diversity (2 peaks) on eosinophils compared to gammadeltaT cells (Figure 5C), while no signal was detected on eosinophils for the 2 other rearrangements, in contrast to gammadeltaT cells (data not shown). Furthermore, to unambiguously demonstrate that TCR rearrangements occur in eosinophils, at single cell level, we performed in situ hybridization using sequences from rearranged TCR genes as RNA probes. Hybridization with anti-sense probes corresponding to Vdelta2-Cdelta and VgammaI-JgammaP rearrangements, that were detected by RT-PCR, gave a positive signal on nuclei from eosinophils at times clearly bilobed. In keeping with RT-PCR results, a significantly stronger signal was detected on gammadelta T lymphocytes, while corresponding sense probes only gave background amplification on both cell types (Fig. 5D). Vdelta1-Jdelta4 anti-sense probe gave positive signal on gammadelta T lymphocytes but not on eosinophils in which this rearrangement was not detected by RT-PCR.
###end p 35
###begin title 36
###xml 59 64 <span type="species:ncbi:9606">human</span>
gammadeltaTCR/CD3 complex expression and rearrangements in human peripheral blood eosinophils.
###end title 36
###begin p 37
###xml 269 277 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s005">Table S1</xref>
###xml 393 401 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s006">Table S2</xref>
###xml 831 838 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 132 136 <span type="species:ncbi:307630">Colo</span>
###xml 170 174 <span type="species:ncbi:307630">Colo</span>
###xml 471 475 <span type="species:ncbi:307630">Colo</span>
(A) Real time PCR analysis of expression of individual chains from gammadeltaTCR/CD3 complex in eosinophils, gammadelta T cells and Colo-205 cells. Average expression in Colo-205 cells is chosen as reference (samples were analysed in triplicate using primers listed in Table S1). (B) TCRgamma and delta rearrangements in peripheral blood eosinophils analysed by RT-PCR using primers listed in Table S2. CD8 amplification is performed to exclude lymphocyte contamination. Colo-205 are chosen as negative control (C) Spectratyping analysis of CDR3 length profiles for Vgamma9-Jgamma1/2 ; Vgamma9-JgammaP and Vdelta2-Cdelta families in eosinophils and in gammadelta T cells from the same donor. (D) Expression of rearranged gamma and deltaTCR at the single cell level in peripheral blood eosinophils and gammadeltaT cells detected by in situ hybridization using anti-sense and control sense probes specific for Vdelta2-Cdelta, VgammaI-JgammaP and for Vdelta1-Jdelta4 used as negative control.
###end p 37
###begin p 38
###xml 352 360 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g006">Figure 6</xref>
Finally, DNA sequencing of Vdelta1Jdelta3 Vdelta2-Cdelta regions from eosinophils and gammadeltaT cells show that V and J regions were virtually identical to the IMGT sequence, while significant differences between eosinophils and 2 different cloned sequences of gammadeltaT cells from the same donor were found in D regions and in junctional regions (Figure 6). This further confirms that gammadeltaTCR/CD3 complex expressed by eosinophils is less expressed and diverse than the corresponding receptor on gammadelta T cells.
###end p 38
###begin title 39
Intraindividual variability between eosinophils and gammadeltaT cells in rearranged Vdelta1-Jdelta3 and Vdelta2-Cdelta TCR sequences.
###end title 39
###begin p 40
(A) TCR locus organization with positions of the PCR probes used for sequence amplification. (B-C) Sequence alignment of Vdelta1-Jdelta3 (B) and Vdelta2-Cdelta (C) regions analyzed from IGMT database, differentiated gammadeltaT cells and peripheral blood eosinophils obtained from the same allergic donors for. The two most frequent sequences are presented for gammadeltaT cells. Grey boxes indicate mismatch.
###end p 40
###begin title 41
gammadeltaTCR/CD3-mediated eosinophil activation induces ROS production, degranulation and cytokine release
###end title 41
###begin p 42
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Gounni1">[6]</xref>
###xml 431 440 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g007">Figure 7A</xref>
###xml 516 531 496 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g007">Figure 7D and G</xref>
###xml 661 662 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 677 681 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Espinosa1">[37]</xref>
###xml 745 760 717 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g007">Figure 7B and E</xref>
###xml 822 826 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Thompson1">[38]</xref>
###xml 932 947 904 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g007">Figure 7C and F</xref>
###xml 1294 1298 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly1">[10]</xref>
###xml 1456 1471 1400 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g007">Figure 7H and I</xref>
###xml 643 648 <span type="species:ncbi:9606">human</span>
###xml 1564 1569 <span type="species:ncbi:9606">human</span>
Upon activation, eosinophils very rapidly produce Reactive Oxygen Species (ROS) and release, by selective degranulation, eosinophil-specific granule proteins, including highly cytotoxic cationic proteins such as EPO and eosinophil cationic protein (ECP) [6]. In purified blood eosinophils, gammadeltaTCR/CD3 complex activation by immobilized antibodies to CD3, gammadeltaTCR or Vdelta1 led to a similar kinetics of ROS production (Figure 7A) and to a significant EPO and eosinophil-derived neurotoxin (EDN) release (Figure 7D and G). Stimulation with a soluble ligand, bromohydrin pyrophosphate (BrHPP), a phosphoantigen agonist selective for human gamma9delta2+ T lymphocytes [37], induced dose-dependent ROS production as well as EPO release (Figure 7B and E). Furthermore, eosinophil activation by sec-butylamine (SBA) [38], an inducer of endogenous phosphoantigens, yielded to a sustained dose-dependent ROS and EPO production (Figure 7C and F), comparable to values obtained following activation with IgA/anti-IgA immune complexes, one potent physiological eosinophil activator. Of note, plate-bound antibodies induced stronger ROS release but weaker EPO release than soluble gammadeltaTCR activators. Since eosinophils also release several immuno-regulatory and proinflammatory cytokines [10], we further show that activation with anti-CD3, -gammadeltaTCR or -Vdelta1 antibodies efficiently induced IFN-gamma and TNF-alpha production by eosinophils (Figure 7H and I). Thus, gammadeltaTCR/CD3-expressing eosinophils respond to selective agonists similarly to human gammadeltaT lymphocytes and produce both specific eosinophil granule proteins, myeloid cell mediators as well as cytokines.
###end p 42
###begin title 43
Specific mediator release upon CD3- or gammadeltaTCR-induced eosinophil activation.
###end title 43
###begin p 44
###xml 307 308 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1171 1179 <span type="species:ncbi:9606">patients</span>
(A-C) Representative time course of ROS production following eosinophil activation by immunobilized specific antibodies (A), BrHPP (B) or SBA stimulation (C). (A) Stimulation with immobilized anti-CD3 (blacksquare, square, filled), anti-gammadeltaTCR (X) or anti-Vdelta1 (black triangle) mAbs or control IgG1 (diamond). (B) Stimulation by BrHPP 200 nM (o) 100 nM (blacksquare, square, filled) and 50 nM (lozenge) or culture medium (diamond). (C) Stimulation by SBA 500 microM (square) 50 microM (black triangle) and 5 microM (X), culture medium (diamond) or IgA/anti-IgA immune complexes (*). (D-F) EPO release by eosinophils upon CD3 or gammadeltaTCR activation by specific antibodies (D) (n = 6), BrHPP (E) (n = 3) or SBA stimulation (F) (n = 3). Results are expressed in count per second (cps). (G) EDN release by eosinophils upon CD3 or gammadeltaTCR activation by specific antibodies (n = 6). (H-I) Cytokine production by eosinophils upon CD3 or gammadeltaTCR activation by specific antibodies or IgA/anti-IgA immune complexes. IFN-gamma production (H) (n = 5-7) and TNF-alpha production (I) (n = 4-8). Results presented in panels E and F were obtained on different patients. *, P<0.05; **, P<0.01.
###end p 44
###begin title 45
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 0 19 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Mycobacterium bovis induce gammadeltaTCR/CD3-dependent eosinophil activation
###end title 45
###begin p 46
###xml 267 271 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lasco1">[39]</xref>
###xml 311 318 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 503 522 487 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 582 593 566 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g008">Figure 8A&#8211;B</xref>
###xml 683 687 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Groh1">[40]</xref>
###xml 689 700 665 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g008">Figure 8C&#8211;D</xref>
###xml 870 881 838 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g008">Figure 8E&#8211;H</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 107 115 <span type="species:ncbi:9606">Patients</span>
###xml 503 522 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Human gammadeltaT cells respond to non-peptide antigens including mycobacterial and tumor-derived ligands. Patients with mycobacterial infections may exhibit blood and tissue eosinophilia and mycobacteria-induced eosinophil-associated experimental acute inflammation [39] as well as rapid eosinophil chemotaxis in vivo. Mycobacteria- eosinophil interactions might thus reflect the reactivity conferred by gammadeltaTCR/CD3 complex. Accordingly, incubation of blood eosinophils with increasing ratios of Mycobacterium bovis-BCG induced dose-dependent ROS production and EPO release (Figure 8A-B), that could be inhibited, in a dose-dependent manner, by an anti-gammadeltaTCR antibody [40] (Figure 8C-D). Similar eosinophil activation, and inhibition by an anti-gammadeltaTCR antibody, was also obtained following incubation with TUBag, a natural mycobacterial component (Figure 8E-H). Thus mycobacteria appear capable of activating eosinophils, at least partly, in a gammadeltaTCR-dependent manner.
###end p 46
###begin title 47
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 0 19 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Mycobacterium bovis-BCG-induced eosinophil activation.
###end title 47
###begin p 48
(A and E) Dose-dependent ROS production by BCG- (A) or TUBag (E) activated eosinophils. BCG/eosinophil ratio: 20/1 (*), 10/1 (lozenge), 5/1 (+) and 0/1 (-). (B and F) Dose-dependent EPO release by eosinophils activated by different BCG/eosinophil ratios (n = 3) (B) or TUBag concentrations (F). (C and G) Inhibition of BCG- (ratio 20/1 *) (C) or TUBag- (G) induced ROS production by an anti-gammadeltaTCR blocking antibody 5 microg/ml (x) and 10 microg/ml (o) or an isotype control antibody (Delta). (D and G) Inhibition of BCG- (D) or TUBag- (G) induced EPO production by an anti-gammadeltaTCR blocking antibody (5 and 10 microg/ml) or an isotype control antibody. Results are expressed as DeltaEPO cps values (values from medium stimulation are subtracted from values obtained with BCG stimulation for each antibody) (n = 3). (E-F) *, P<0.05; **, P<0.01.
###end p 48
###begin title 49
gammadeltaTCR/CD3-dependent eosinophil cytotoxicity toward tumor cells
###end title 49
###begin p 50
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 96 100 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Hayday2">[41]</xref>
###xml 117 121 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Munitz1">[19]</xref>
###xml 369 377 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 471 480 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g009">Figure 9A</xref>
###xml 666 675 634 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g009">Figure 9B</xref>
###xml 815 826 775 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g009">Figure 9C&#8211;D</xref>
###xml 262 266 <span type="species:ncbi:307630">Colo</span>
###xml 348 352 <span type="species:ncbi:307630">Colo</span>
Eosinophils have been associated with many tumors in vivo. Furthermore, both gammadelta T cells [41] and eosinophils [19] exert potent cytotoxic activity towards many tumor cells. Therefore, we investigated gammadeltaTCR-mediated eosinophil cytotoxicity towards Colo-205 carcinoma cell line. Indeed, eosinophils induced time-dependent apoptosis of Colo-205 tumor cells in vitro, which was significantly inhibited following addition of neutralizing anti-gammadeltaTCR Ab (Figure 9A). This effect was more prominent at earlier time-points suggesting that gammadeltaTCR-mediated eosinophil-tumor interactions are important for the initiation of the cytotoxic reaction (Figure 9B). Finally preincubation of eosinophils with gammadeltaTCR ligands, SBA and TUBag, potentiated eosinophil cytotoxicity towards tumor cells (Figure 9C-D). Altogether, these data confirm the potential role of eosinophils in anti-tumor cytotoxicity and strongly suggest the involvement of gammadeltaTCR/CD3 complex in this mechanism.
###end p 50
###begin title 51
###xml 46 51 <span type="species:ncbi:9606">human</span>
gammadeltaTCR-dependent tumor-cell killing by human eosinophils.
###end title 51
###begin p 52
###xml 131 132 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A-B) Induction of Colo205 killing by eosinophils and inhibition by an anti-gammadeltaTCR blocking antibody. Percentage of AnnexinV+ tumor cells in the presence or absence of eosinophils and blocking anti-gammadeltaTCR or isotype control antibodies (n = 5-7) at various time-points. Panel A represents the 60 min time-point. (C-D) Potentiation of eosinophil-mediated Colo205 killing by gammadeltaTCR ligands. (C) 50 microM SBA (n = 7). (D) 20 mM TUBag (n = 4). *, P<0.05; **, P<0.01.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 411 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Rand1">[42]</xref>
###xml 417 421 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lucey2">[18]</xref>
###xml 450 454 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Woerly1">[10]</xref>
###xml 676 680 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Boullier1">[35]</xref>
###xml 745 748 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Kayaba1">[9]</xref>
###xml 1690 1691 1595 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
We here provide evidence that highly purified human blood eosinophils, as well as eosinophils differentiated in vitro from CD34+ cord blood progenitors, gated on the basis of presence of specific eosinophil granule proteins, express a functional gammadeltaTCR/CD3 complex, so far almost exclusively associated to T lymphocytes, but lack alphabetaTCR. As previously observed for other receptors such as CD25 [42], CD4 [18], FcepsilonRI, CD89 and CD28 [10], gammadeltaTCR/CD3 surface expression on eosinophils is highly heterogeneous between individual donors. Such an heterogeneity in gammadeltaTCR/CD3 expression has also been observed for human blood gammadeltaT lymphocytes [35]. As it is the case for several receptors, including FcepsilonRI [9], surface expression of gammadeltaTCR/CD3 can be induced/up-regulated, in particular upon incubation with ligands. Our results show that gammadeltaTCR surface expression was induced upon incubation in the presence of a natural mycobacterial ligand as well as following overnight culture. The molecular mechanism underlying this later finding remains unknown. Our results indicate that CD3epsilon expression, both at mRNA and protein levels, was consistently lower than gammadeltaTCR. Due to the requirement of this CD3 subunit for surface expression of the receptor complex, it is tempting to speculate that the very low CD3epsilon expression probably accounts for the low surface expression of the whole complex on eosinophils although further experiments would be required for a formal demonstration. This low receptor expression as well as the fragility of eosinophils was a constraint to obtain significant amounts of viable gammadeltaTCR+ eosinophils following cell sorting.
###end p 54
###begin p 55
###xml 300 304 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Krejci1">[43]</xref>
###xml 315 319 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Fronkova1">[44]</xref>
###xml 451 452 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 460 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 637 641 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Couedel1">[45]</xref>
Eosinophils display a rearranged gammadeltaTCR with a more restricted repertoire compared to gammadeltaT cells, further excluding the possibility of lymphocyte contaminants in eosinophil preparations. Besides T lymphocytes, deltaTCR rearrangements have only been reported in malignant B lymphoblasts [43], NK cells [44] and in mixed-type leukaemia retaining both T-lymphoid and myeloid characteristics. Furthermore, presence of double positive Vdelta1+Vdelta2+ and equal numbers of Vdelta1- and Vdelta2-expressing eosinophils in most of normal donors suggests incomplete allelic exclusion as found in some instances in gammadeltaT cells [45]. Direct gammadeltaTCR activation of eosinophils by gammadeltaTCR/CD3-specific antibodies and selective agonists induced eosinophil-specific responses. Release of such myeloid-associated mediators and the scarcity of circulating gammadelta T cells further exclude the possibility that our results obtained using highly purified eosinophils would be due to gammadeltaTCR expression by contaminating lymphocytes.
###end p 55
###begin p 56
###xml 288 292 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Shigematsu1">[46]</xref>
###xml 453 457 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Kawamoto1">[47]</xref>
###xml 556 560 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Xie1">[48]</xref>
###xml 722 725 714 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Jacobsen2">[8]</xref>
###xml 883 887 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Sehmi1">[49]</xref>
###xml 1256 1260 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lee1">[50]</xref>
###xml 1342 1346 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-deAndres1">[51]</xref>
###xml 1365 1369 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Decot1">[52]</xref>
###xml 1559 1563 1519 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Jameson1">[53]</xref>
###xml 1631 1635 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-OBrien1">[54]</xref>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 1081 1086 <span type="species:ncbi:10090">mouse</span>
###xml 1156 1161 <span type="species:ncbi:10090">mouse</span>
###xml 1204 1209 <span type="species:ncbi:9606">human</span>
###xml 1447 1452 <span type="species:ncbi:10090">mouse</span>
###xml 1457 1463 <span type="species:ncbi:9606">humans</span>
###xml 1536 1541 <span type="species:ncbi:10090">mouse</span>
###xml 1553 1558 <span type="species:ncbi:9606">human</span>
###xml 1576 1581 <span type="species:ncbi:9606">human</span>
Thus, mature eosinophils expressing lymphoid markers might represent hitherto unattended gammadeltaTCR-expressing myeloid cells. Our results might be in agreement with observations that myeloid-derived plasmacytoid DC are able to express a "lymphoid program" (RAG1, rearranged IgH genes) [46]. By contrast, in the recently proposed myeloid-based model of haematopoiesis, T- or B-committed progenitors would each keep a myeloid-differentiation potential [47]. For instance, genetic reprogramming from differentiated B cells to macrophages has been reported [48]. Further experiments are required to unravel by which mechanisms eosinophils have acquired this lymphoid program. Of note, eosinophils are found in human thymus [8]. Furthermore, similarly to gut intraepithelial gammadeltaT cells, eosinophils are able to undergo peripheral differentiation, for instance in allergic lungs [49]. Investigating TCR expression by eosinophils in various organs and tissues would greatly benefit from experiments on animal models. Unfortunately, we were unable to detect gammadeltaTCR/CD3 on mouse blood and tissue eosinophils. This is not extremely surprising since mouse eosinophils are strikingly different from human eosinophils, regarding their granular content [50] and membrane expression of various immune receptors, in particular IgE receptors [51] and IgA receptors [52]. Furthermore, gammadeltaT cells also display significant differences between mouse and humans. Indeed, a high proportion of skin lymphocytes express gammadeltaTCR in mouse but not in human [53], while only human Vgamma9Vdelta2 are responsive to phosphoantigens [54].
###end p 56
###begin p 57
###xml 464 467 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Kayaba1">[9]</xref>
###xml 550 554 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Hsu1">[55]</xref>
###xml 572 576 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Choy1">[56]</xref>
###xml 606 610 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lasco1">[39]</xref>
###xml 654 689 626 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis in vitro</italic>
###xml 689 693 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Borelli1">[57]</xref>
###xml 933 937 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Thedrez1">[58]</xref>
###xml 1020 1024 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Thedrez1">[58]</xref>
###xml 1330 1334 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Lee1">[50]</xref>
###xml 1483 1487 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-FernandezAcenero1">[59]</xref>
###xml 1658 1662 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Bennouna1">[60]</xref>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 654 680 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Our findings indicate that eosinophils might also contribute, through gammadeltaTCR-dependent mechanisms, to immune defences in tissues, where 90% eosinophils are located. One might speculate that gammadeltaTCR/CD3 expression is higher in tissue than in blood eosinophils, as previously reported for FcepsilonRI in a model of "humanized" mice where human FcepsilonRI was quantified and increasingly expressed from blood to peritoneal cavity and spleen eosinophils [9]. Tissue eosinophils are associated to granulomatous diseases such schistosomiasis [55], Crohn's disease [56] and mycobacterial infections [39]. Eosinophils can damage cell wall and lyse Mycobacterium tuberculosis in vitro[57]. Vgamma9delta2 and Vdelta1 expression, rapid response to phosphoantigen ligands, as well as BCG-induced activation so far represented hallmarks of gammadeltaT lymphocyte-mediated cytotoxicity towards phosphoantigen-expressing mycobacteria [58]. Since tumors produce phosphoantigens and are targeted by gammadeltaT lymphocytes [58], gammadeltaTCR-mediated activation might thus contribute to the anti-tumoral activity of eosinophils. Indeed, while gammadeltaT lymphocytes and NK cells display granzyme B/perforin-mediated cytotoxicity, eosinophils additionally possess a unique set of cationic proteins with a strong cytotoxic potential [50]. Furthermore, tumor-associated tissue eosinophilia (TATE) is considered by some authors as a marker of good prognosis, including in colon carcinoma [59]. Anti-tumoral activity of eosinophils should be considered in the context of current development of innovative cancer immunotherapies, based on synthetic phosphoantigens [60]. Indeed, due to their high cytotoxic potential and despite their low gammadeltaTCR expression in comparison to T cells, eosinophils might thus represent very efficient "innate" effector cells in defence against targets bearing gammadeltaTCR ligands, such as tumor cells, in particular when eosinophils surround or infiltrate solid tumors.
###end p 57
###begin p 58
Our work outlines a previously unexpected link between eosinophils and gammadeltaT lymphocytes, which not only share the expression of the gammadeltaTCR/CD3 complex but also some major functions in innate immunity. It might also shed light on the molecular mechanisms of differentiation, diversity and function of T-cell expressed gammadeltaTCR.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin title 60
Ethics statement
###end title 60
###begin p 61
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Peripheral venous blood was obtained from healthy donors or eosinophilic patients after written informed consent. Research protocol was approved by the Comite Consultatif de Protection des Personnes dans la Recherche Biomedicale de Lille (France).
###end p 61
###begin title 62
Cell purification and culture
###end title 62
###begin p 63
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Legrand1">[61]</xref>
Eosinophils were isolated as described [61] on Percoll followed by negative selection using anti-CD16-coated microbeads. Purity determined after cytospin and RAL555 staining was above 98% and 100% for RNA analyses. Purified eosinophils were cultured overnight at 37degreesC in complete RPMI without phenol red.
###end p 63
###begin p 64
###xml 370 371 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 566 567 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 590 597 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 626 627 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Neutrophils were obtained by positive selection with anti-CD16 coated microbeads. Purity was 99%. For RNA extraction, alphabetaTCR lymphocytes from PBMC from normal donors were sorted after staining with anti-alphabetaTCR-PE using FacsAriatrade mark cell sorter and Divatrade mark software (BD). Purity was 99%. gammadeltaTCR lymphocytes were generated from PBMC (0.5x106/ml) by culture in complete RPMI 1640 medium with 200 nM bromohydrin pyrophosphate BrHPP (Innate Pharma, Marseille) and 20 ng/ml rhIL-2 for 7 days. At that time, 50-70% cells were gamma9delta2TCR+ cells. For RT-PCR and in situ hybridization, gammadeltaTCR+ cells were further purified using anti-gammadeltaTCR microbeads (Miltenyi).
###end p 64
###begin p 65
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 339 340 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Cord blood was obtained from the maternity unit of Lille University Hospital. Mononuclear cells were isolated by Ficoll-Hypaque density centrifugation. CD34+ cells were purified using CD34+ isolation kit (Miltenyi). Purified CD34+ cells were cultured in complete medium supplemented with 2.5x10-5 M beta-mercaptoethanol (beta-ME) at 0.5x106 cells/ml. Eosinophil differentiation was induced upon addition of 50 ng/ml SCF, 1 ng/ml each GM-CSF, IL-3 and IL-5 (Peprotech).
###end p 65
###begin p 66
###xml 0 4 <span type="species:ncbi:307630">Colo</span>
Colo-205 colon carcinoma cell line was obtained from ATCC. Cells were maintained in RPMI 1640 medium supplemented with 10% FCS, 10 mM L-Glutamine and 10 microg/ml Gentamycin.
###end p 66
###begin title 67
Flow cytometry
###end title 67
###begin p 68
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s005">Table S1</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Plager1">[62]</xref>
###xml 525 529 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Herzenberg1">[63]</xref>
###xml 197 201 <span type="species:ncbi:162683">Mayo</span>
Antibodies and isotype controls used for flow cytometry (origin, clone, working dilution or concentration) are listed in Table S1. Anti-EPO (AHE) and anti-MBP2 [62] (a kind gift from Dr. D Plager, Mayo Clinic, Rochester) were biotinylated using biotin-sulfosuccinimidyl ester (Molecular Probes) according to manufacturer's instructions and used at a 1:100 dilution. Samples were analysed on a FACSCaliburtrade mark using CellQuesttrade mark software (BD). Multiple staining experiments are represented as color density plots [63] with linear scales used for both forward (FSC) and side scatter (SSC) and logarithmic scales used for fluorescence parameters (Log density: 50%).
###end p 68
###begin p 69
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
Intracellular staining was performed after fixation of purified eosinophils, neutrophils or PBMC (2x105) with 2% paraformaldehyde and permeabilization with 0.01% saponin in PBS. After blocking of non-specific binding with 5 microl mouse serum for 10 min, cells were incubated with anti-CD3-FITC, anti-alphabetaTCR-FITC, anti-gammadeltaTCR-FITC or anti-CD8-FITC or corresponding isotype controls for 30 min in the presence of saponin.
###end p 69
###begin p 70
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Constant1">[36]</xref>
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005926-g001">Figure 1B</xref>
###xml 533 534 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Following incubation for 2 h with or without TUBag-1 [36] (40 nM) in RMPI 1640 or after overnight culture, purified blood eosinophils were gated prior to the analysis, on the basis of their FSC and SSC characteristics in order to exclude dead cells (Figure 1B). Within PBMC fraction, monocytes and lymphocytes were gated on the basis of their FSC and SSC characteristics prior to the analysis. Quadrants were set on samples after double staining with FITC- or APC- and PE- or biotin-conjugated control isotype antibodies. At least 104 events were acquired per sample.
###end p 70
###begin p 71
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
For double and triple staining, cultured peripheral eosinophils were preincubated with 5% human serum albumin (HSA) for 30 min at 4degreesC and labelled for membrane receptor with the relevant fluorochrome-conjugated antibodies. After washing, cells were fixed 10 min with 2% paraformaldehyde at 4degreesC and permeabilized for 10 min at room temperature (RT) with 0.01% saponin in PBS-1% BSA. Non-specific binding was blocked with 5 microl mouse serum for 10 min. Purified peripheral blood eosinophils were further identified by incubation with biotinylated anti-EPO or anti-MBP or isotype control for 30 min and streptavidin-PE (Molecular Probes) (1:200) for 20 min in the presence of saponin. Neutrophils were identified by intracellular staining with anti-MPO-PE following an identical procedure. Monocytes and T lymphocytes were identified by staining with anti-CD14-PE, anti-alphabetaTCR or anti-gammadeltaTCR respectively.
###end p 71
###begin title 72
Immunofluorescence and confocal microscopy
###end title 72
###begin p 73
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 353 359 <span type="species:ncbi:9793">donkey</span>
###xml 469 473 <span type="species:ncbi:9925">goat</span>
###xml 598 602 <span type="species:ncbi:9925">goat</span>
###xml 733 739 <span type="species:ncbi:9793">donkey</span>
###xml 745 749 <span type="species:ncbi:9925">goat</span>
Purified eosinophils were cytocentrifuged, fixed in 4% paraformaldehyde, washed in 0.05 M PBS. Fixation was stopped with 0.1 M glycine for 4 min and 50 mM NH4Cl pH 7.4 for 15 min. After each incubation step, cytospins were washed for 10 min in PBS. Cells were incubated with PBS-3% BSA-5% HSA for 30 min and, after one PBS wash, with 10% decomplemented donkey serum (Jackson ImmunoResearch). Cytospins were then incubated overnight at 4degreesC in a humid chamber with goat antibodies specific for CD3epsilon, CD3zeta, CD3gamma, CD3delta, alphaTCR, betaTCR, gammaTCR, deltaTCR (Santa Cruz) or with goat IgG (Jackson ImmunoResearch) in PBS-BSA-HSA (40 microg/ml). After washing in PBS-0.1% BSA, cells were incubated with biotinylated donkey anti-goat IgG (Jackson ImmunoResearch) (1:200) in PBS-BSA-HSA for 2 hours, followed by streptavidin-Texas Red (Molecular Probes) (1:500) in PBS-3% BSA for 1 hour. Final washes were with PBS-0.1% BSA- 0.02% Tween 20 for 2x10 min and with PBS for 10 min. For immunofluorescence, DNA was stained with Hoechst 33342 (Invitrogen) (1:1000), immediately prior to cytospin mounting in Fluoromount G (Southern Biotechnologies).
###end p 73
###begin p 74
For conventional immunofluorescence a Leica DM-RB microscope equipped for epifluorescence with a 100 W mercury lamp was used. Filter and dichroic mirror sets were TX2 for Texas Red and A for Hoechst 33342. Images were acquired with a 100x1.32 NA oil immersion objective, a Photometrics Cool SNAPtrade mark camera using RSImagetrade mark software (Roper Scientific). Samples were analysed by confocal microscopy using a DM-IRE2 inverted microscope with SP2-AOBS scan-head (Leica) at the Imaging Facility of Institut Pasteur de Lille. Excitation was performed at 543 nm for Texas Red. Fluorescence emission wavelengths pass bands were selected between 581 and 621 nm according to the emission spectral analysis. Excitation power was between 100 and 400 microW. Acquisitions were performed using a 100x1.4 NA oil immersion objective. 3D pre-treatment, analysis and edition were performed with Edit3D (free software, Y. Usson, GDR2588, CNRS, France). Analysis and editing was performed on Photoshop (Adobe).
###end p 74
###begin title 75
Surface immunoprecipitation
###end title 75
###begin p 76
###xml 106 110 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Hayes1">[64]</xref>
###xml 231 232 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Surface labelling and co-immunoprecipitation was performed as previously described for gammadelta T cells [64]. Purified human eosinophils or differenciated gammadeltaT cells were washed and then resuspended in PBS (pH 8.0) at 3.107 cells/ml at room temperature. Surface biotinylation was performed for 30 min at room temperature using 2 mM Sulfo-NHS-LC-Biotin (Pierce Biotechnology). Cells were washed three times with PBS containing 100 nM glycine and once in PBS.
###end p 76
###begin p 77
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 737 739 720 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
Labelled cells were lysed in a buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, protease inhibitors and 1% Brij 97 (Sigma-Aldrich). Lysates were cleared by centrifugation for 15 min at 12,000 g and sequentially incubated at 4degreesC in the presence of Protein-G Sepharose (Gamma bind Plus Sepharose, Pharmacia), Protein G Sepharose-bound normal mouse IgG (Jackson Immunoresearch) and Protein G Sepharose-bound anti-gammadeltaTCR. Immunoprecipitated samples were washed three times with lysis buffer then boiled in reducing sample buffer (30 mM Tris, pH 6.8, 5% glycerol, 2% SDS, 2.5% beta-mercaptoethanol, 0.1% bromophenol blue). Material was run on 14% polyacrylamide gels. Material corresponding to the total and to 1/10th of the material was loaded for eosinophils and gammadeltaT cells respectively. Following separation, proteins were transferred to PVDF membrane (Biorad). Blots were developed using ABC-HRP (Vector Laboratories) and the enhanced chemiluminescence (ECL) plus Western blot detection system (Amersham).
###end p 77
###begin title 78
PCR analysis
###end title 78
###begin p 79
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 258 266 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s006">Table S2</xref>
Total RNA was isolated using the RNeasy mini kit (Qiagen) from 107 purified cells and reverse transcription was performed using SuperScripttrade markRT (MMLV 200 U/microl) (Invitrogen). cDNA was amplified using primers (Proligo) (20 pmoles/microl) listed in Table S2. PCR were run for 40 cycles (1 min at 95degreesC, 1 min annealing and 1 min at 72degreesC) using Taq polymerase (Bioprobe).
###end p 79
###begin title 80
Real time PCR
###end title 80
###begin p 81
Total RNA was prepared from eosinophils by guanidium/CsCl centrifugation method. Briefly, purified eosinophils were pelleted by centrifugation and then lysed in 4 M guanidium isothiocyanate, 1 mM EDTA, 25 mM sodium acetate, 4.9% beta-mercaptoethanol, 68 mM N-lauryl sarcosine. Lysate was drawn through a 20G needle. RNA was obtained by ultracentrifugation (28000 rpm, 20 h, and 20degreesC) through a CsCl gradient. RNA pellet was washed twice and dissolved in water and precipitated overnight at -20degreesC with ethanol 70% and sodium acetate 0.08 M. After centrifugation (10000 rpm, 45 minutes at 4degreesC), RNA was washed twice in ethanol 70%, resuspended in water and store at -80degreesC until use. RNA from gammadelta T cells and Colo205 cells was prepared using RNeasy mini-spin columns (Qiagen, UK) according to the manufacturer's instructions. All samples were quantified by absorbance measurement at 260 nm on a spectrophotometer (Biorad), and RNA quality was checked by running samples on 1.5% agarose gel in RNA loading buffer (Sigma).
###end p 81
###begin p 82
###xml 508 516 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005926.s006">Table S2</xref>
Total RNA was first submitted to DNAse I (Invitrogen) treatment (15 min at room temperature), and cDNA was generated using Superscript II reverse transcriptase (Invitrogen) according to the manufacturer instructions. Samples were analyzed by quantitative real-time PCR, performed according to manufacturer's protocol, using SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7000 Sequence Detection System (Applied Biosystems). Primers were designed using the Primer3 Website and are listed on Table S2.
###end p 82
###begin p 83
###xml 446 458 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;C</sup>
###xml 467 471 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Livak1">[65]</xref>
Samples were run in triplicate in a reaction volume of 25 microl. Amplification was carried out for 40 cycles, with denaturation at 95degreesC for 10 min during the first cycle and subsequently for 15 seconds, annealing and extension for 1 minute at 60degreesC. A dissociation temperature gradient was included at the end of the run. Gene expression was normalized according to GAPDH expression. Relative gene expression was calculated with the 2-DeltaDeltaCT method [65].
###end p 83
###begin title 84
TCR repertoire analysis
###end title 84
###begin p 85
###xml 217 221 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Douillard1">[66]</xref>
Qualitative analysis of CDR3 length for Vgamma9-Jgamma1/2, Vgamma9-JgammaP and Vdelta2-Cdelta families was performed in triplicate on eosinophils and in gammadelta T cells from the same donor (TcLand, Nantes, France) [66]. Briefly, cDNA was amplified by PCR using a Cgamma or Cdelta reverse primer and Vgamma9 or Vdelta2-specific forward primers, respectively. The amplifications were performed in a 384-Well GeneAmp(R) PCR System 9700 (Applied Biosystems, Foster City, CA). Briefly, each amplification product was used for an elongation reaction using a dye-labeled Jgamma specific-labelled primer for the rearrangement analysis and Cdelta labeled primer for the delta chain analysis, then heat denatured, loaded at least in duplicate onto a sequencing analyzer (48-capillary 3730 DNA Analyzer - Applied Biosystems). Then, GeneMapper software (Applied Biosystems) was used to display the distribution profiles of CDR3 lengths, in amino acids, of the amplified and elongated products.
###end p 85
###begin title 86
gammadeltaTCR junctional sequences analysis
###end title 86
###begin p 87
Vdelta1-Jdelta3 and Vdelta2-Cdelta amplification products (400 bp) were cloned into a TA vector (pCR-TOPO, Invitrogen) using standard protocols. For each rearrangement, sequencing was performed on 5 randomly picked clones. TCR sequences were obtained from the IMGT website (imgt.cines.fr). Sequence alignments were performed using DNAstar software. GeneBank sequence accession numbers are: FJ890312 and FJ890313 respectively.
###end p 87
###begin title 88
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ hybridisation
###end title 88
###begin p 89
###xml 502 506 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Wilkinson1">[67]</xref>
###xml 508 515 472 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1003 1008 <span type="species:ncbi:10090">mouse</span>
###xml 1087 1093 <span type="species:ncbi:9986">rabbit</span>
###xml 1099 1104 <span type="species:ncbi:10090">mouse</span>
PCR products, amplified from purified gammadeltaTCR lymphocyte RNA, and corresponding to VgammaI-JgammaP, Vdelta2-Cdelta and Vdelta1-Jdelta4 rearrangements were cloned into the pCRII-TOPO vector (Invitrogen). Clones were isolated and sequenced on both strands. Clones corresponding to the published sequence were used to generate hybridization probes. Sense and anti-sense probes were synthesised from linearised plasmids using 350 microM digoxigenin-UTP (Roche) and SP6 or T7 polymerases as described [67]. In situ hybridisation was performed using a Discovery automat and corresponding kits (Ventana Medical Systems). Slides were incubated in EZprep buffer before processing with a standard RiboMap Kit. Slides were pre-treated 30 min with CC2 buffer, then 20 min with protease 3, followed by 6 h hybridization with sense or anti-sense probes (100 ng/slide). Slides were then washed twice 10 min in 2x SSC at 60degreesC, twice 10 min in 0.1x SSC at 60degreesC. Slides were incubated for 30 min with a mouse anti-digoxigenin antibody (Jackson ImmunoResearch) and then for 30 min with a rabbit anti-mouse antibody before treatment with UltraMap kit. Labelling was detected after a 150 min (Vdelta2-Cdelta), 110 min (VgammaI-JgammaP) or 90 min (Vdelta1-Jdelta4) incubation in the presence of NBT/BCIP substrate. Slides were counterstained for 1 h with Nuclear Fast Red and mounted in permanent mounting medium (Vector).
###end p 89
###begin title 90
ROS production and EPO release
###end title 90
###begin p 91
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Legrand1">[61]</xref>
###xml 121 122 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 265 266 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 307 308 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 696 697 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 844 846 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 874 875 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 876 877 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
ROS production and EPO release were measured as described [61]. Wells were coated with 10 microg/ml anti-mouse IgG F(ab')2 (Sigma) for 2 h at 37degreesC, followed by incubation with 10 microg/ml anti-CD3, anti-gammadeltaTCR, anti-Vdelta1or isotype control mouse IgG1 for 2 h at 37degreesC. Eosinophils (2x106/ml) were added in the presence of luminol (8.3 microg/ml). Alternatively, eosinophils were stimulated with 50-200 nM BrHPP, 5-50 microM sec-butylamine (SBA) (Sigma) or IgA/anti-IgA immune complexes (incubation with 7.5 microg/ml secretory IgA for 1 hr then by addition of 10 microg/ml anti-IgA). Chemiluminescence was measured at 37degreesC for 5 sec/timepoint with a luminometer (Victor2trade mark Wallac). For EPO release, supernatants (50 microl) were transferred into a microtiterplate and luminol (50 microg/ml), D-luciferin (4x10-5M) (Roche Diagnostics) and H2O2 were injected.
###end p 91
###begin title 92
EDN and cytokine release
###end title 92
###begin p 93
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Eosinophils (2x106/ml) were activated with the same stimuli as for ROS production. After 18 h culture, supernatants were collected. EDN levels were measured by specific ELISA (MBL). The lower detection limit was 0.62 ng/ml. IFNgamma and TNFalpha cytokines were measured by specific ELISA (Diaclone). Detection limit was 5 pg/ml for IFNgamma and 8 pg/ml for TNFalpha.
###end p 93
###begin title 94
Activation with Mycobacteria
###end title 94
###begin p 95
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 0 19 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Mycobacterium bovis-BCG Pasteur strain was obtained from Dr C. Locht (Inserm U629, Institut Pasteur de Lille, France) and was grown in Sauton medium at 37degreesC. Eosinophils were incubated with various BCG numbers (Eosinophil/BCG: 20/1, 10/1 and 5/1). ROS and EPO release were determined as described above. For inhibition experiments, eosinophils (20/1 ratio) were incubated with a blocking anti-gammadeltaTCR mAb (10 microg/ml) or isotype control for 30 min at 37degreesC, before BCG addition.
###end p 95
###begin title 96
Tumor cell apoptosis
###end title 96
###begin p 97
###xml 225 226 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 313 317 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005926-Legrand1">[61]</xref>
###xml 0 4 <span type="species:ncbi:307630">Colo</span>
###xml 163 167 <span type="species:ncbi:307630">Colo</span>
Colo 205 cells were labelled with 10 microM PKH26 (Sigma) according to manufacturer's instructions. Then, eosinophil-mediated cytotoxicity against PKH-26-labelled Colo-205 (10 microM) was measured in complete medium at 1.6x104 targets/well into U-bottom plates containing eosinophils (25:1 Effector:Target ratio) [61]. After different time points, apoptosis was measured by flow cytometry after annexinV-FITC staining (Pharmingen) for 15 min at RT. For inhibition experiments, blocking antibodies against gammadeltaTCR or isotype-matched control (10 microg/ml) were added to eosinophils immediately prior to the incubation in the presence of targets. In some experiments, eosinophils were preincubated for 30 min with 50 microM SBA or 20 mM TUBAg 1 before addition to the target cells.
###end p 97
###begin title 98
Statistical analysis
###end title 98
###begin p 99
Individual data or mean+/-S.E.M values were presented. All statistical analyses were performed using SPSS software. Normality of data samples was assessed with the Normality test of Shapiro and Wilk. Then parametric paired-samples Student's t-test was used to compare variables and the one-tailed statistical significance level was as represented on Figures.
###end p 99
###begin title 100
Supporting Information
###end title 100
###begin p 101
Gating strategy and specific identification of purified peripheral blood eosinophils in flow cytometry analysis. (A-B) Gating of purified peripheral blood eosinophils on forward and side scatter parameters immediately after purification. (A) Ellipsoids circle the analyzed population. (B). Specificity of eosinophil identification by intracellular detection of EPO, MBP or MPO using PE- or biotin-conjugated specific antibodies (grey shaded histograms). Staining on purified neutrophils as well as gated lymphocytes and monocytes from purified PBMC is shown as control. Staining with control isotype matched antibodies is represented in white histograms.
###end p 101
###begin p 102
(6.41 MB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 224 225 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 327 328 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Surface expression of CD3, gammadeltaTCR, Vgamma9, Vdelta2,Vdelta1, alphabetaTCR, CD8 and NKG2D detected by flow cytometry in double staining on immune cell populations. (A) In vitro-generated BrHPP-induced gamma9 delta2 TCR+ lymphocytes. (B) Scatter-gated lymphocytes from PBMC. (C) Scatter-gated monocytes from PBMC. (D) CD16+-purified blood neutrophils. Staining with control isotype matched antibodies is represented.
###end p 104
###begin p 105
(4.23 MB TIF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 202 203 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Surface expression of gammadeltaTCR/CD3 complex by human eosinophils following induction by a mycobacterial gammadeltaTCR ligand. (A-B) CD3, gammadeltaTCR, alphabetaTCR and CD8 surface expression on EPO+-purified peripheral blood eosinophils incubated with culture medium (A) or with 40 nM TubAg for 2 h (B). Staining with control isotype matched antibodies is represented.
###end p 107
###begin p 108
(3.02 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 113 114 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 229 230 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Surface expression of CD3, gammadeltaTCR and CD8 on cord blood-derived eosinophils. Eosinophils derived from CD34+ cord blood cells (day 21) were analysed for CD3, gammadeltaTCR and CD8 cell surface expression after gating on EPO+ cells. Staining with control isotype antibodies is represented.
###end p 110
###begin p 111
(1.28 MB TIF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
List, and characteristics of antibody used in this manuscript. Mb: Membrane staining. IC: Intracellular staining
###end p 113
###begin p 114
(0.06 MB DOC)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
Gene-specific primer sequences
###end p 116
###begin p 117
(0.04 MB DOC)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 357 361 <span type="species:ncbi:162683">Mayo</span>
The authors wish to thank M. Bonneville (Inserm, Nantes, France), J. Khalife (Inserm, Lille) for helpful advices. They are grateful to L. Prin (CHRU, Lille France) and the National Network on Hypereosinophilia for access to eosinophilic patients, C. Rouanet and C. Locht (Inserm, Lille, France) for providing BCG and technical suggestions and Dr D. Plager (Mayo Clinic, Rochester) for anti-MBP2 antibody. The authors also with to thank M. Delbecke and J. Bertout for their technical assistance.
###end p 119
###begin title 120
References
###end title 120
###begin article-title 121
Pharmacology of the eosinophil.
###end article-title 121
###begin article-title 122
The eosinophil.
###end article-title 122
###begin article-title 123
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells.
###end article-title 123
###begin article-title 124
Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma.
###end article-title 124
###begin article-title 125
###xml 41 46 <span type="species:ncbi:9606">human</span>
Mechanism of membrane damage mediated by human eosinophil cationic protein.
###end article-title 125
###begin article-title 126
High-affinity IgE receptor on eosinophils is involved in defence against parasites.
###end article-title 126
###begin article-title 127
###xml 76 81 <span type="species:ncbi:9606">human</span>
Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.
###end article-title 127
###begin article-title 128
Eosinophils: singularly destructive effector cells or purveyors of immunoregulation?
###end article-title 128
###begin article-title 129
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation.
###end article-title 129
###begin article-title 130
###xml 31 36 <span type="species:ncbi:9606">human</span>
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by Immunoglobulin A complexes.
###end article-title 130
###begin article-title 131
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human eosinophils express and release IL-13 following CD28-dependent activation.
###end article-title 131
###begin article-title 132
Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.
###end article-title 132
###begin article-title 133
###xml 7 12 <span type="species:ncbi:9606">human</span>
Mature human eosinophils have the capacity to express HLA-DR.
###end article-title 133
###begin article-title 134
Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86.
###end article-title 134
###begin article-title 135
Lymph node trafficking and antigen presentation by endobronchial eosinophils.
###end article-title 135
###begin article-title 136
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit.
###end article-title 136
###begin article-title 137
Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
###end article-title 137
###begin article-title 138
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 77 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120.
###end article-title 138
###begin article-title 139
###xml 43 48 <span type="species:ncbi:9606">human</span>
2B4 (CD244) is expressed and functional on human eosinophils.
###end article-title 139
###begin article-title 140
Ultrastructural, cytochemical and functional studies on the eosinophilic granulocytes of larval lampreys.
###end article-title 140
###begin article-title 141
###xml 35 40 <span type="species:ncbi:9606">human</span>
House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
###end article-title 141
###begin article-title 142
###xml 66 71 <span type="species:ncbi:9606">human</span>
Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
###end article-title 142
###begin article-title 143
###xml 74 79 <span type="species:ncbi:9606">human</span>
Expression of and functional responses to protease-activated receptors on human eosinophils.
###end article-title 143
###begin article-title 144
TLR2-dependent eosinophil interactions with mycobacteria : role of alpha-defensins.
###end article-title 144
###begin article-title 145
Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
###end article-title 145
###begin article-title 146
###xml 77 104 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.
###end article-title 146
###begin article-title 147
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense.
###end article-title 147
###begin article-title 148
An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.
###end article-title 148
###begin article-title 149
The eosinophil-mediated antitumor activity of interleukin-4.
###end article-title 149
###begin article-title 150
###xml 46 51 <span type="species:ncbi:9606">human</span>
Professional antigen-presentation function by human gammadelta T Cells.
###end article-title 150
###begin article-title 151
Gamma delta cells: a right time and a right place for a conserved third way of protection.
###end article-title 151
###begin article-title 152
Gamma delta T cells: functional plasticity and heterogeneity.
###end article-title 152
###begin article-title 153
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
###end article-title 153
###begin article-title 154
###xml 48 53 <span type="species:ncbi:9606">human</span>
A variable immunoreceptor in a subpopulation of human neutrophils.
###end article-title 154
###begin article-title 155
Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones.
###end article-title 155
###begin article-title 156
###xml 15 20 <span type="species:ncbi:9606">human</span>
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.
###end article-title 156
###begin article-title 157
###xml 96 101 <span type="species:ncbi:9606">human</span>
Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.
###end article-title 157
###begin article-title 158
Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway.
###end article-title 158
###begin article-title 159
###xml 53 64 <span type="species:ncbi:10141">guinea pigs</span>
###xml 79 105 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis.
###end article-title 159
###begin article-title 160
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.
###end article-title 160
###begin article-title 161
Immunoregulation in the tissues by gammadelta T cells.
###end article-title 161
###begin article-title 162
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human eosinophils express functional interleukin 2 receptors.
###end article-title 162
###begin article-title 163
Cutting edge: TCR delta gene is frequently rearranged in adult B lymphocytes.
###end article-title 163
###begin article-title 164
Lymphoid Differentiation Pathways Can Be Traced by TCR {delta} Rearrangements.
###end article-title 164
###begin article-title 165
###xml 119 124 <span type="species:ncbi:9606">human</span>
Allelic exclusion at the TCR delta locus and commitment to gamma delta lineage: different modalities apply to distinct human gamma delta subsets.
###end article-title 165
###begin article-title 166
Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin.
###end article-title 166
###begin article-title 167
A close developmental relationship between the lymphoid and myeloid lineages.
###end article-title 167
###begin article-title 168
Stepwise reprogramming of B cells into macrophages.
###end article-title 168
###begin article-title 169
###xml 19 24 <span type="species:ncbi:9606">human</span>
Differentiation of human eosinophils. Role in allergic inflammation.
###end article-title 169
###begin article-title 170
Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?
###end article-title 170
###begin article-title 171
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections.
###end article-title 171
###begin article-title 172
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils.
###end article-title 172
###begin article-title 173
Skin gammadelta T-cell functions in homeostasis and wound healing.
###end article-title 173
###begin article-title 174
Gammadelta T-cell receptors: functional correlations.
###end article-title 174
###begin article-title 175
###xml 52 71 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Eosinophils as effector cells in the destruction of Schistosoma mansoni eggs in granulomas.
###end article-title 175
###begin article-title 176
Activated eosinophils in chronic inflammatory bowel disease.
###end article-title 176
###begin article-title 177
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 78 104 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis.
###end article-title 177
###begin article-title 178
###xml 32 37 <span type="species:ncbi:9606">human</span>
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?
###end article-title 178
###begin article-title 179
Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma.
###end article-title 179
###begin article-title 180
###xml 159 167 <span type="species:ncbi:9606">patients</span>
Phase-I study of Innacell gammadeltatrade mark, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.
###end article-title 180
###begin article-title 181
Innate immune functions of eosinophils. From antiparasite to antitumor cells.
###end article-title 181
###begin article-title 182
###xml 47 52 <span type="species:ncbi:9606">human</span>
Major basic protein homolog (MBP2): a specific human eosinophil marker.
###end article-title 182
###begin article-title 183
Interpreting flow cytometry data: a guide for the perplexed.
###end article-title 183
###begin article-title 184
Distinct structure and signaling potential of the gamma delta TCR complex.
###end article-title 184
###begin article-title 185
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 185
###begin article-title 186
Selection of T cell clones with restricted TCR-CDR3 lengths during in vitro and in vivo alloresponses.
###end article-title 186
###begin article-title 187
Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts.
###end article-title 187
###begin p 188
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 188
###begin p 189
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Work was funded by Inserm (French National Institutes for Health and Medical Reserach), Pasteur Institute Lille (a not for profit Research Institute), University Lille - Nord de France and ANR (French National Research Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 189

